Chemotherapy at home services is an outpatient care option provided by a team of doctors and nurses, allowing cancer patients to receive their treatments at home. Chemotherapy at-home services provide cancer patients with the option to receive chemotherapy treatments in the comfort of their own homes rather than in traditional clinical settings such as hospitals or specialized treatment centers.
Sizing and Forecast
The chemotherapy at-home services market size has grown rapidly in recent years. It will grow from $1.58 billion in 2023 to $1.75 billion in 2024 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to increased cancer incidence, growing patient demand for receiving care at home, hospital capacity constraints, improved home healthcare infrastructure, and supportive government policies.
The chemotherapy at-home services market size is expected to see rapid growth in the next few years. It will grow to $2.68 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to rising healthcare costs, aging population, expansion of home healthcare services, increased focus on patient-centric care, increased need to reduce inpatient stays and chronic disease management. Major trends in the forecast period include integration of AI and machine learning, personalized medicine approaches, wearable health technology, growth of specialty home infusion services, and collaborative healthcare models.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/chemotherapy-at-home-services-global-market-report
Segmentation & Regional Insights
The chemotherapy at home services market covered in this report is segmented –
1) By Product: Chemotherapy Drugs, Chemotherapy Infusion Pumps
2) By Administration: Oral, Intravenous
3) By Application: Breast Cancer, Blood Cancer, Ovarian Cancer, Colorectal Cancer
North America was the largest region in the chemotherapy at-home services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemotherapy at home services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15762&type=smp
Major Driver Impacting Market Growth
The increased prevalence of cancer is expected to propel the growth of the chemotherapy-at-home services market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells in the body. There is an increased prevalence of cancer due to several factors such as aging populations, lifestyle changes, environmental exposures, genetic predispositions, and increased detection through advanced diagnostic techniques. Chemotherapy at-home services allow cancer patients to receive treatment in the comfort of their own homes, improving convenience and quality of life. For instance, in 2021, according to the American Cancer Society, a US-based community-based, voluntary health organization, there were an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States in 2021, an increase from 1.8 million new cancer cases diagnosed and 606,520 cancer deaths reported in 2020. Therefore, the increased prevalence of cancer is driving the growth of chemotherapy at-home services.
Key Industry Players
Major companies operating in the chemotherapy at home services market are CVS Health Corporation, Optum Inc, Fresenius Kabi, Medtronic plc, Amgen, Penn Medicine, Advocate Health Care, Medibank Private Limited, Option Care Health Inc., Amedisys Inc., Lincare Holdings Inc., Cancer Treatment Centers of America (CTCA), BioScrip Inc., Shanghai MicroPort Lifesciences Co. Ltd., Accredo Health Group Inc., LloydsPharmacy Clinical Homecare, InfuSystem Holdings Inc., Portea Medical, Amerita Inc., Jivika Healthcare, Vitalis Health and Home Care Pty Ltd, Ubiqare Health Pvt. Ltd., View Health Pty Ltd group, Sciensus Pharma Services Limited, TCP Homecare
The chemotherapy at home services market report table of contents includes:
- Executive Summary
- Chemotherapy At Home Services Market Characteristics
- Chemotherapy At Home Services Market Trends And Strategies
- Chemotherapy At Home Services Market – Macro Economic Scenario
- Global Chemotherapy At Home Services Market Size and Growth
…………….
- Global Chemotherapy At Home Services Market Competitive Dashboard
- Key Mergers And Acquisitions In The Chemotherapy At Home Services Market
- Chemotherapy At Home Services Market Future Outlook and Potential Analysis
- Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Chemotherapy At Home Services Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Chemotherapy At Home Services Market, Segmentation By Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Chemotherapy At Home Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
………….
Table 74: CVS Health Corporation Financial Performance
Table 75: Optum Inc Financial Performance
Table 76: Fresenius Kabi Financial Performance
Table 77: Medtronic plc Financial Performance
Table 78: Amgen Financial Performance
Explore the trending research reports from TBRC:
https://goodprnews.com/electronic-grade-hydrofluoric-acid-market-size/
https://topprnews.com/future-of-cv-depot-charging-market-size/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
